All patients improved in all categories. Erythema scores fell from 2-0 (0-2) at baseline to 0-1 (0-0) after 8 weeks of topical cyclosporin (p=0-03); erosion scores fell from 2-4 (0-5) to 0-3 (0-2) (not significant, n &mdash; 4 only), and reticulation scores decreased from 1 -7 (0-2) to 0-7 (0-2) (p=0&deg;03). All six patients experienced significant discomfort before therapy with an average pain score of 22 (0-2). After treatment the pain score was only 0-(0-1) (p = 0-03) with complete relief noted by four patients. All six noted transient burning of the mucosal surfaces while swishing the medication. Four reported slight precipitation, resulting in waxy particles which could easily be spat out.
In four patients, cyclosporin levels in whole blood were undetectable (less than 20 ng/ml) or low (30-60 ng/ml); in the other two peaks of 176 and 184 ng/ml were recorded, but in only one of these were moderate concentrations (60-90 ng/ml) persistent. 
